Nuclear Medicine Equipment Market Growth 2030: Theranostics, AI Imaging & Precision Medicine Driving the Future
The global nuclear medicine equipment market is on a steady growth trajectory, projected to reach USD 8.31 billion by 2030, up from USD 6.63 billion in 2025, expanding at a CAGR of 4.6% during the forecast period. This growth is largely fueled by the increasing burden of chronic diseases such as cancer and cardiovascular disorders, alongside the rising demand for early, accurate, and non-invasive...
Bioactive Dressings Market: Transforming Advanced Wound Care Through Innovation
The global healthcare industry is witnessing a significant transformation in wound management, driven by the growing demand for advanced healing solutions. Among these innovations, bioactive dressings have emerged as a crucial component in modern wound care, offering enhanced healing properties that go beyond traditional wound coverings. According to recent market research, the global Bioactive Dressings...
Fill Finish Manufacturing Market Poised for Strong Growth as Demand for Sterile Injectable Therapies Accelerates
The global pharmaceutical industry is witnessing a transformative shift toward biologics, biosimilars, personalized medicines, and advanced injectable therapies. At the center of this evolution is fill finish manufacturing—a critical stage in pharmaceutical production that ensures sterile drug products are accurately filled into their final containers and prepared for patient use.
According to...
Cell-Based Assays Market Poised to Reach USD 25.77 Billion by 2030: Accelerating Drug Discovery and Precision Medicine
The global life sciences industry is increasingly turning to advanced cellular analysis technologies to accelerate drug discovery, improve therapeutic development, and support personalized medicine initiatives. Among these technologies, cell-based assays have emerged as indispensable tools for evaluating biological responses, drug efficacy, toxicity, and disease mechanisms.
According to recent...
Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | Growth and outlook
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029. Rising outsourcing of development and manufacturing to CDMOs and growing focus on precision/personalized medicine are some of the factors driving the market’s...
High-Throughput Screening Market Set to Reach USD 45.90 Billion by 2031: Accelerating the Future of Drug Discovery
The global pharmaceutical and biotechnology industries are under increasing pressure to develop safer, more effective therapies in less time. As drug discovery programs become more complex and data-intensive, high-throughput screening (HTS) technologies have emerged as a critical enabler of modern research. According to the latest market analysis, the global High-Throughput Screening (HTS) Market...
Quantum Computing in Healthcare: Revolutionizing Drug Discovery, Genomics, and Precision Medicine
The healthcare industry is entering a new era of technological innovation, and quantum computing is emerging as one of the most transformative forces shaping the future of medical research and patient care. As healthcare systems generate increasingly complex datasets and face growing demands for faster therapeutic development, traditional computing methods are often unable to process biological complexities...
AI in Hospital Operations Market Growth 2030: Transforming Healthcare Efficiency with Automation, NLP & Predictive Analytics
The global AI in hospital operations market is witnessing explosive growth, projected to surge from USD 7.51 billion in 2025 to USD 25.70 billion by 2030, expanding at an impressive CAGR of 27.9%. This rapid acceleration is driven by mounting pressures on healthcare systems worldwide, including workforce shortages, rising administrative complexity, and the urgent need to enhance operational efficiency...
Patient Safety and Risk Software : Driven by Rising Focus on Clinical Quality and Regulatory Compliance
The global Patient Safety and Risk Software Market is projected to grow from USD 1.75 billion in 2025 to USD 2.99 billion by 2030, registering a CAGR of 11.3% during the forecast period. The market is witnessing strong growth as healthcare organizations increasingly prioritize reducing medical errors, improving patient outcomes, and ensuring regulatory compliance.
The...